Safety and Quality Control
MEDINET processes tissues and cells that are used for medical treatment, and we believe that our most important task is to provide safe and high-quality technologies and services to patients and healthcare providers so that they can use those tissues and cells with peace of mind.
MEDINET has prioritized this task since it first started supporting cell processing for medical treatment used in immuno-cell therapy in 1999. To provide safe and high-quality regenerative medicine and cell therapy, we have accumulated extensive expertise, established detailed quality assurance systems, including a manufacturing quality control system for safely conducting cell processing, cell processing facilities (CPFs) or alternatively cell processing centers (CPCs) optimized for regenerative medicine and cell therapy, and a transport management system.
Regenerative medicine and cell therapy involves processing patients’ own cells and tissues at CPFs and using them to restore and regenerate lost tissues and organs. Our CPFs abide by laws concerning regenerative medicine and cell therapy (The Act on the Safety of Regenerative Medicine and The Act on Pharmaceuticals and Medical Devices [PMD Act]). We have also established a strong safety control system using our expertise accumulated over 16 years.